Skip to content

Evaluation of the Contribution of Lower Limb and/or Abdominal Compression on Orthostatic Hypotension

Evaluation of the Contribution of Lower Limb and/or Abdominal Compression on Orthostatic Hypotension.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06694688
Acronym
HYPOFLEX
Enrollment
43
Registered
2024-11-19
Start date
2025-02-14
Completion date
2026-02-10
Last updated
2026-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthostatic Hypotension

Keywords

orthostatic hypotention, abdominal compression, Lower limb compression

Brief summary

Orthostatic hypotension (OH) is associated with an increased risk of myocardial infarction, stroke, heart failure and neurocognitive disorders. In the elderly, OH is an independent predictor of falls and mortality. Non-drug treatments are used as the first-line treatments. Among non-drug treatments, compression of the lower limbs and abdominal compression have been shown to help reduce OH and associated symptoms. As these studies were solely based on ankle-to-thigh bandages, the effectiveness of other medical devices developed, such as compression socks and tights, needs to be evaluated. In addition, data comparing the efficacy and tolerability of several approaches, single or combined, of several levels of compression, provided by socks, tights and an abdominal belt are scarce. The HYPOFLEX study aims to provide new data to enable better management of OH.

Detailed description

Patients will be recruited from a single center, over a 12-month inclusion period. The clinical investigation will focus on CE-marked Class I medical devices, used for their intended purpose, as part of a post-market clinical follow-up with additional non-invasive, non-invasive procedures. Randomization will be carried out to determine the order of the 5 conditions studied: * No compression, * Class 2 compression socks, * Class 3 compression socks, * Class 2 compression tights, * Dynabelt abdominal belt + Class 2 compression socks. Conditions will be tested over half a day.

Interventions

DIAGNOSTIC_TESTthe supine/standing postural change test

The prevalence of orthostatic hypotension will be characterized by the percentage of patients with a decrease of ≥ 20mmHg in systolic blood pressure or ≥ 10mmHg in diastolic blood pressure following the supine/standing postural change position.

Sponsors

Gérond'if
Lead SponsorOTHER
Thuasne
CollaboratorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

44 patients will be included in this study. Randomization will be carried out to determine the order of the 5 conditions studied: * No compression, * Class 2 compression socks, * Class 3 compression socks, * Class 2 compression tights, * Dynabelt abdominal belt + Class 2 compression socks.

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient aged 60 or over, * Patients hospitalized at Broca Hospital with orthostatic hypotension, * Patient able to stand, * Patient who has been medically stable for at least 48 hours, * Patient whose measurements are compatible with Thuasne compression device sizes, * Patient having been informed, having received answers to his questions and having signed the informed consent form prior to his participation in the study, * Patient affiliated or entitled to a social security number.

Exclusion criteria

* Patients presenting, according to the investigator, a contraindication to lower limb and/or abdominal compression, * Patients presenting any contraindication mentioned in the instructions for use of the medical devices under investigation. * Patient presenting, according to the investigator, a major cognitive impairment incompatible with participation in a clinical trial, * Patient taking part in another clinical investigation conducted to establish the conformity of a medical device having an impact on the outcomes, * Vulnerable patient according to article L1121-6 of the Public Health Code, subject to a judicial protection measure or incapable of consenting to a clinical trial or incapable of giving informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Compare the blood pressure reduction induced by supine/standing postural change in the absence and presence of lower limb compression.12 monthsDecrease in systolic BP when moving from the supine to the standing position, using a semi-automatic blood pressure monitor (Dynamap type): * supine BP: average of 3 measurements taken after a rest of at least 5 minutes * BP in upright position: lowest value of measurements obtained every minute for 5 minutes after rising, Without compression and with class 2 compression of the lower limbs.

Secondary

MeasureTime frameDescription
Decrease in systolic blood pressure when moving from the supine to the upright position12 monthsThe following evaluation criteria will be compared in the absence and presence of compression and between the different compression devices: * The difference between supine SBP/DBP (average of last 3 measurements) and standing SBP/DBP (lowest value of 5 measurements) will be calculated, * The prevalence of orthostatic hypotension will be characterised by the percentage of patients with a decrease in systolic BP ≥ 20mmHg or ≥ 10mmHg in diastolic BP following the supine/standing postural change position, * The time to onset of orthostatic hypotension will be calculated from the 5 measurements of BP measured in orthostasis,
Severity of orthostatic hypotension12 monthsThe severity of orthostatic hypotension will be assessed by the percentage of patients with an orthostatic systolic BP \<90mmHg, following the supine/standing postural change position, \- Symptoms associated with orthostatic hypotension will be assessed using the Orthostatic Hypotension Symptoms Assessment questionnaire (OHQ), consisting of 6 questions at the end of all pressure measurements.
Characterize orthostatic hypotension12 monthsCharacterize orthostatic hypotension at inclusion (neurogenic, hypovolemic, cardiogenic, drug-induced).
Evaluate patient satisfaction and tolerance12 monthsEvaluate patient satisfaction and tolerance with the use of compression devices.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026